Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2008(15): 2398-2404
DOI: 10.1055/s-2008-1067129
DOI: 10.1055/s-2008-1067129
PAPER
© Georg Thieme Verlag
Stuttgart ˙ New York
An Efficient Synthesis of ABT-263, a Novel Inhibitor of Antiapoptotic Bcl-2 Proteins
Further Information
Received
27 February 2008
Publication Date:
11 June 2008 (online)
Publication History
Publication Date:
11 June 2008 (online)
Abstract
ABT-263, a newly developed Bcl-2 inhibitor, was efficiently synthesized. The key intermediates 4-(4-{[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-enyl]methyl}piperazin-1-yl)benzoic acid and 4-fluoro-3-[(trifluoromethyl)sulfonyl]benzenesulfonamide were efficiently prepared by a three-component Mannich reaction and by nucleophilic fluorination of 1-nitro-2-[(trifluoromethyl)sulfonyl]benzene as the key steps, respectively. Our work may lay a foundation for a new process development of this promising anticancer drug candidate.
Key words
Bcl-2 family protein inhibitor - anticancer drugs - ABT-263 - synthesis - sulfonamides
- 1
Adams JM.Cory S. Science 1998, 281: 1322 - 2
Cory S.Adams JM. Nat. Rev. Cancer 2002, 2: 647 - 3
Minn AJ.Swain RE.Ma A.Thompson CB. Adv. Immunol. 1998, 70: 245 - 4
Van D MF.Huang DC. Cell Res. 2006, 16: 203 - 5
Thompson CB. Science 1995, 267: 1456 - 6
Reed JC. Adv. Pharmacol. 1997, 41: 501 - 7
Danial NN.Korsmeyer SJ. Cell 2004, 116: 205 - 8
Nicholson DW. Nature 2000, 407: 810 - 9
Green DR.Evan GI. Cancer Cell 2002, 1: 19 - 10
Amundson SA.Myers TG.Scudiero D.Kitada S.Reed JC.Fornace AJ. Cancer Res. 2000, 60: 6101 - 11
Danial NN. Clin. Cancer Res. 2007, 13: 7254 - 12
Adams JM.Cory S. Oncogene 2007, 26: 1324 - For reviews, see:
-
13a
Beauparlant P.Shore GC. Cell Eng. 2004, 4: 223 -
13b
Hangary S.Johnson DE. Leukemia 2003, 17: 1470 -
13c
Huang ZW. Curr. Opin. Drug Discovery Dev. 2000, 3: 565 -
13d
Wang S.Yang D.Lippman ME. Semin. Oncol. 2003, 30: 133 -
13e
Manion MK.Fry J.Schwartz PS.Hockenbery DM. Curr. Opin. Investig. Drugs 2006, 7: 1077 -
13f
Reed JC.Zhai D.Hyer M.Welsh K. Drug Discovery Res. 2007, 408 - 14
Degterev A.Lugovskoy A.Cardone M.Mulley B.Wagner G.Mitchison T.Yuan J. Nat. Cell Biol. 2001, 3: 173 - 15
Wang JL.Liu D.Zhang ZJ.Shan S.Han X.Srinivasula SM.Croce CM.Alnemri ES.Huang Z. Proc. Natl. Acad. Sci. U.S.A. 2000, 97: 7124 - 16
Tzung SP.Kim KM.Basanez G.Giedt CD.Simon J.Zimmerberg J.Zhang KY.Hockenbery DM. Nat. Cell Biol. 2001, 3: 183 - 17
Kitada S.Leone M.Sareth S.Zhai D.Reed JC.Pellecchia M. J. Med. Chem. 2003, 46: 4259 - 18
Oltersdorf T.Elmore SW.Shoemaker AR.Armstrong RC.Augeri DJ.Belli BA.Bruncko M.Deckwerth TL.Dinges J.Hajduk PJ.Joseph MK.Kitada S.Korsmeyer SJ.Kunzer AR.Letai A.Li C.Mitten MJ.Nettesheim DG.Ng S.Nimmer PM.O’Connor JM.Oleksijew A.Petros AM.Reed JC.Shen W.Tahir SK.Thompson CB.Tomaselli KJ.Wang B.Wendt MD.Zhang H.Fesik SW.Rosenberg SH. Nature 2005, 435: 677 - 19
Tang G.Ding K.Nikolovska-Coleska Z.Yang C.-Y.Qiu S.Shangary S.Wang R.Guo J.Gao W.Meagher J.Stuckey J.Krajewski K.Jiang S.Roller PP.Wang S. J. Med. Chem. 2007, 50: 3163 - 20
Xing C.Saleh M.Pitot H.Hartung J.Holmlund J.AlbertLoBuglio A.Forero AP. The 2005 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery Biology and Clinical Applications, Nov 14-18, 2005, Philadelphia, Pennsylvania American Association for Cancer Research; Philadelphia, PA: 2005. Abstract C89. - 21
Zhang Z.Jin L.Qian X.Wei M.Wang Y.Wang J.Yang Y.Xu Q.Xu Y.Liu F. ChemBioChem 2007, 8: 113 - 22
Petros AM.Dinges J.Augeri DJ.Baumeister SA.Betebenner DA.Bures MG.Elmore SW.Hajduk PJ.Joseph MK.Landis SK.Nettesheim DG.Rosenberg SH.Shen W.Thomas S.Wang X.Zanze I.Zhang H.Fesik SW. J. Med. Chem. 2006, 49: 656 - 23
Wendt MD.Wang S.Kunzer A.McClellan WJ.Bruncko M.Oost TK.Joseph MK.Nimmer PM.Ng S.-C.Shoemaker AR.Petros AM.Oleksijew A.Marsh K.Bauch J.Oltersdorf T.Belli BA.Martineau D.Fesik SW.Rosenberg SH.Elmore SW. J. Med. Chem. 2006, 49: 1165 - 24
Bruncko M.Oost TK.Belli BA.Ding H.Joseph MK.Kunzer A.Martineau D.McClellan WJ.Mitten M.Ng S.-C.Nimmer PM.Oltersdorf T.Park C.-M.Petros AM.Shoemaker AR.Song X.Wang X.Wendt MD.Zhang H.Fesik SW.Rosenberg SH.Elmore SW. J. Med. Chem. 2007, 50: 641 - 25
Park CM.Oie T.Petros AM.Zhang H.Nimmer PM.Henry RF.Elmore SW. J. Am. Chem. Soc. 2006, 128: 16206 - 27
Lock R.Carol H.Houghton PJ.Morton CL.Kolb EA.Gorlick R.Reynolds CP.Maris JM.Keir ST.Wu J.Smith MA. Pediatr. Blood Cancer 2008, 50: 1181 - 28
Bruncko M,Ding H,Elmore SW,Kunzer AR,Lynch CL,McClellan WJ,Park CM,Song X, andWang X. inventors; US 27135A1. ; Chem. Abstr. 2007, 146, 229049 - 29
Steven W,Bruncko M, andPark CM. inventors; US 272744. ; Chem. Abstr. 2005, 144, 36377 - 30
Dai K.Minoru I.Mikio Y.Shoichi M.Mitsugu H.Kiyoaki K.Keiichi A. Bioorg. Med. Chem. 2006, 14: 2089 - 31
Ying C.Chun C. J. Fluorine Chem. 2005, 126: 937 - 32
Bandgar BP.Bettigeri SV.Phopase J. Org. Lett. 2004, 6: 2105 - 33
Beaumont AJ.Clark JH. J. Fluorine Chem. 1991, 52: 295 - 34
Popkova VY, andMarhold A. inventors; EP 109892. ; Chem. Abstr. 1999, 132, 3248
References
Park C. M.; Abstracts, 41st Western Regional Meeting of the American Chemical Society; San Diego, 2007.